Asensus Surgical (TransEnterix) is an American medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company was founded in 2006 and is based in Morrisville, North Carolina.
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Asensus Surgical (TransEnterix) news
05.05.2022
Asensus Surgical's GAAP loss for the 3 months of 2022 was $19.128 million, up 10.3% from $17.34 million in the prior year. Revenue decreased 48.8% to $1.066 million from $2.083 million a year earlier.
Source: 
ir.asensus.com
ir.asensus.com
01.03.2022
Asensus Surgical's GAAP loss for 2021 was $62.462 million, up 5.3% from $59.312 million the previous year. Revenue increased 2.6 times to $8.232 million from $3.175 million a year earlier.
Source: ir.asensus.com
ir.asensus.com
04.11.2021
Asensus Surgical reported a GAAP loss of $46.581 million for 9M 2021, up 2.3% from $45.521 million in the previous year. Revenue increased 2.8 times to $5.756 billion from $2.068 billion a year earlier.
Source: ir.asensus.com
ir.asensus.com
06.08.2021
Asensus Surgical's GAAP loss for six months of 2021 was $30.512 million, up 0.2% from $30.438 million in the prior year. Revenue increased 2.5 times to $3.185 million from $1.255 million a year earlier.
Source: ir.asensus.com
ir.asensus.com
General information
| Company name | Asensus Surgical (TransEnterix) |
|---|---|
| Tags | #medtech |
| Sector | Health Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment |
| Business address | 635 Davis Drive Suite 300 Morrisville, NC 27560 United States |
| Mailing address | 635 Davis Drive Suite 300 Morrisville, NC 27560 United States |
| Website | ir.transenterix.com |
| Information disclosure | www.sec.gov |
English (US) 